CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.250
-0.060 (-2.60%)
At close: Jun 27, 2025, 4:00 PM
2.290
+0.040 (1.78%)
After-hours: Jun 27, 2025, 7:54 PM EDT
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $354.47 million as of June 27, 2025. Its market cap has increased by 205.32% in one year.
Market Cap
354.47M
Enterprise Value
282.74M
1-Year Change
205.32%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has decreased from $464.70M to $354.47M, a decrease of -23.72%. That is a compound annual growth rate of -2.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 181.40M | 125.06% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 61.78% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |